Genetic dominance influences blood biomarker levels in a sample of 12,000 Swedish elderly twins

Twin Research and Human Genetics

Volumn 12, Issue 3, 2009, Pages 286-294

  Rahman, Iffat ^a   Bennet, Anna M ^a   Pedersen, Nancy L ^a   De Faire, Ulf ^a,b   Svensson, Per ^b   Magnusson, Patrik K E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CVD biomarkers; Heritability; Swedish twins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIZYGOTIC TWINS; FEMALE; GENE STRUCTURE; GENETIC ANALYSIS; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEREDITY; HERITABILITY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MONOZYGOTIC TWINS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; TWINS;

AGED; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENES, DOMINANT; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGISTRIES; SWEDEN; TRIGLYCERIDES; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC;

EID: 67249113559     PISSN: 18324274     EISSN: None     Source Type: Journal    
DOI: 10.1375/twin.12.3.286     Document Type: Article

References (47)

1. Abney, M., McPeek, M. S., & Ober, C. (2001). Broad and narrow heritabilities of quantitative traits in a founder population. American Journal of Human Genetics, 68, 1302-1307. (Pubitemid 32424431)
2. Andrikoula, M., & McDowell, I. F. (2008). The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes, Obesity and Metabolism, 10, 271-278.
3. Bayoumi, R. A., Al-Yahyaee, S. A., Albarwani, S. A., Rizvi, S. G., Al-Hadabi, S., Al-Ubaidi, F. F., Al-Hinai, A. T., Al-Kindi, M. N., Adnan, H. T., Al-Barwany, H. S., Comuzzie, A. G., Cai, G., Lopez-Alvarenga, J. C., & Hassan, M. O. (2007). Heritability of determinants of the metabolic syndrome among healthy Arabs of the Oman family study. Obesity, 15, 551-556.
4. Beekman, M., Heijmans, B. T., Martin, N. G., Pedersen, N. L., Whitfield, J. B., DeFaire, U., van Baal, G. C., Snieder, H., Vogler, G. P., Slagboom, P. E., & Boomsma, D. I. (2002). Heritabilities of apolipoprotein and lipid levels in three countries. Twin Research, 5, 87-97. (Pubitemid 34407936)
5. Berrahmoune, H., Herbeth, B., Siest, G., & Visvikis-Siest, S. (2007). Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: Association with apolipoprotein E alleles. Genes and Immunity, 8, 352-359. (Pubitemid 46888043)
6. Betteridge, D. J., Gibson, J. M., & Sager, P. T. (2007). Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (< 2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study). American Journal of Cardiology, 100, 1245-1248. (Pubitemid 47505225)
7. Chan, D. C., & Watts, G. F. (2006). Apolipoproteins as markers and managers of coronary risk. QJM - Monthly Journal of the Association of Physicians, 99, 277-287.
8. Chen, T. J., Ji, C. Y., Pang, Z. C., Wang, S. J., Hu, Y. H., & Qin, Y. (2004). [Heritability of serum lipids and lipoproteins and its related factors in twins aged 5 to 19 years of China]. Zhonghua Yu Fang Yi Xue Za Zhi, 38, 237-239.
9. Chien, K. L., Hsu, H. C., Chen, W. J., Chen, M. F., Su, T. C., & Lee, Y. T. (2007). Familial aggregation of metabolic syndrome among the Chinese: Report from the Chin-Shan community family study. Diabetes Research and Clinical Practice, 76, 418-424. (Pubitemid 46505041)
10. Clyne, B., & Olshaker, J. S. (1999). The C-reactive protein. Journal of Emergency Medicine, 17, 1019-1025. (Pubitemid 29528076)
11. Dastani, Z., Engert, J. C., Genest, J., & Marcil, M. (2006). Genetics of high-density lipoproteins. Current Opinions in Cardiology, 21, 329-335. (Pubitemid 44315066)
12. De Backer, G., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., et al. (2004). European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Archives des Maladies du Coeur et Des Vaisseaux, 97, 1019-1030.
13. de Oliveira, C. M., Pereira, A. C., de Andrade, M., Soler, J. M., & Krieger, J. E. (2008). Heritability of cardiovascular risk factors in a Brazilian population: Baependi Heart Study. BMC Medical Genetics, 9, 32. (Pubitemid 351712542)
14. Edwards, J. E., & Moore, R. A. (2003). Statins in hypercholesterolaemia: A dose-specific meta-analysis of lipid changes in randomised, double blind trials. BMC Family Practice, 4, 18.
15. Fenger, M., Schousboe, K., Sorensen, T. I., & Kyvik, K. O. (2007). Variance decomposition of apolipoproteins and lipids in Danish twins. Atherosclerosis, 191, 40-47. (Pubitemid 46227427)
16. Fox, E. R., Benjamin, E. J., Sarpong, D. F., Rotimi, C. N., Wilson, J. G., Steffes, M. W., Chen, G., Adeyemo, A., Taylor, J. K., Samdarshi, T. E., & Taylor, H. A., Jr. (2008). Epidemiology, heritability, and genetic linkage of c-reactive protein in African Americans (from the Jackson Heart Study). American Journal of Cardiology, 102, 835-841.
17. Golden, S. H., Selvin, E., & Cunningham, K. E. (2007). Glycaemic status and cardiovascular disease in type 2 diabetes mellitus: Revisiting glycated hemoglobin targets for cardiovascular disease prevention. Diabetes, Obesity and Metabolism, 9, 792-798. (Pubitemid 47555202)
18. Gomez-Gerique, J. A., Ros, E., Olivan, J., Mostaza, J. M., Vilardell, M., Pinto, X., Civeira, F., Hernández, A., da Silva, P. M., Rodriguez-Botaro, A., Zambón, D., Lima, J., Díaz, C., Aristegui, R., Sol, J. M., Chaves, J., Hernández, G., & ATOMIX Investigators. (2002). Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia. Atherosclerosis, 162, 245-251.
19. Goode, E. L., Cherny, S. S., Christian, J. C., Jarvik, G. P., & de Andrade, M. (2007). Heritability of longitudinal measures of body mass index and lipid and lipoprotein levels in aging twins. Twin Research and Human Genetics, 10, 703-711. (Pubitemid 47608003)
20. Gould, A. L., Davies, G. M., Alemao, E., Yin, D. D., & Cook, J. R. (2007). Cholesterol reduction yields clinical benefits: Meta-analysis including recent trials. Clinical Therapy, 29, 778-794. (Pubitemid 47225184)
21. Heller, D. A., de Faire, U., Pedersen, N. L., Dahlen, G., & McClearn, G. E. (1993). Genetic and environmental influences on serum lipid levels in twins. New England Journal of Medicine, 328, 1150-1156. (Pubitemid 23105752)
22. Henneman, P., Aulchenko, Y. S., Frants, R. R., van Dijk, K. W., Oostra, B. A., & van Duijn, C. M. (2008). Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: The Erasmus Rucphen Family study. Journal of Medical Genetics, 45, 572-577.
23. Hokanson, J. E., Langefeld, C. D., Mitchell, B. D., Lange, L. A., Goff, D. C., Jr., Haffner, S. M., Saad, M. F., & Rotter, J. I. (2003). Pleiotropy and heterogeneity in the expression of atherogenic lipoproteins: The IRAS Family Study. Human Heredity, 55, 46-50. (Pubitemid 36928745)
24. Iliadou, A., Lichtenstein, P., de Faire, U., & Pedersen, N. L. (2001). Variation in genetic and environmental influences in serum lipid and apolipoprotein levels across the lifespan in Swedish male and female twins. American Journal of Medical Genetics, 102, 48-58. (Pubitemid 32623265)
25. Iliadou, A., Snieder, H., Wang, X., Treiber, F. A., & Davis, C. L. (2005). Heritabilities of lipids in young European American and African American twins. Twin Research and Human Genetics, 8, 492-498. (Pubitemid 41499490)
26. Isaacs, A., Sayed-Tabatabaei, F. A., Aulchenko, Y. S., Zillikens, M. C., Sijbrands, E. J., Schut, A. F., Rutten, W. P., Pols, H. A., Witteman, J. C., Oostra, B. A., & van Duijn, C. M. (2007). Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: The Erasmus Rucphen Family Study. European Journal of Epidemiology, 22, 99-105. (Pubitemid 46457307)
27. Jialal, I., Stein, D., Balis, D., Grundy, S. M., Adams-Huet, B., & Devaraj, S. (2001). Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. Circulation, 103, 1933-1935. (Pubitemid 32322218)
28. Krauss, R. M., & Kesaniemi, Y. A. (1994). Cardiovascular disease and hyperlipidaemia. Current Opinion in Lipidology, 5, 249-251. (Pubitemid 24249557)
29. Lange, L. A., Burdon, K., Langefeld, C. D., Liu, Y., Beck, S. R., Rich, S. S., Freedman, B. I., Brosnihan, K. B., Herrington, D. M., Wagenknecht, L. E., & Bowden, D. W. (2006). Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study. Annals of Human Genetics, 70, 717-725. (Pubitemid 44530636)
30. Lauer, M. S., & Fontanarosa, P. B. (2001). Updated guidelines for cholesterol management. JAMA, 285, 2508-2509. (Pubitemid 32433846)
31. Martin, N. G., Eaves, L. J., Kearsey, M. J., & Davies, P. (1978). The power of the classical twin study. Heredity, 40, 97-116. (Pubitemid 8257856)
32. McQueen, M. B., Bertram, L., Rimm, E. B., Blacker, D., & Santangelo, S. L. (2003). A QTL genome scan of the metabolic syndrome and its component traits. BMC Genetics, 4 Suppl 1, S96.
33. Middelberg, R. P., Spector, T. D., Swaminathan, R., & Snieder, H. (2002). Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: Effects of menopause. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 1142-1147. (Pubitemid 34764865)
34. Neale MC, Boker SM, Xie G, Maes HH (2006). Mx: Statistical Modeling (7th ed.). VCU Box 900126, Richmond, VA 23298: Department of Psychiatry.
35. Paffen, E., & DeMaat, M. P. (2006). C-reactive protein in atherosclerosis: A causal factor? Cardiovascular Research, 71, 30-39. (Pubitemid 43870060)
36. Santos, R. L., Zillikens, M. C., Rivadeneira, F. R., Pols, H. A., Oostra, B. A., van Duijn, C. M., & Aulchenko, Y. S. (2006). Heritability of fasting glucose levels in a young genetically isolated population. Diabetologia, 49, 667-672. (Pubitemid 43357539)
37. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study. (2000). Circulation, 102, 21-27.
38. Simonis-Bik, A. M., Eekhoff, E. M., Diamant, M., Boomsma, D. I., Heine, R. J., Dekker, J. M., Willemsen, G., van Leeuwen, M., & de Geus, E. J. (2008). The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Research and Human Genetics, 11, 597-602.
39. Snieder, H., Sawtell, P. A., Ross, L., Walker, J., Spector, T. D., & Leslie, R. D. (2001). HbA(1c) levels are genetically determined even in type 1 diabetes: Evidence from healthy and diabetic twins. Diabetes, 50, 2858-2863. (Pubitemid 33733139)
40. Snieder, H., van Doornen, L. J., & Boomsma, D. I. (1999). Dissecting the genetic architecture of lipids, lipoproteins, and apolipoproteins: Lessons from twin studies. Arteriosclerosis, Thrombosis and Vascular Biology, 19, 2826-2834. (Pubitemid 30029806)
41. Souren, N. Y., Paulussen, A. D., Loos, R. J., Gielen, M., Beunen, G., Fagard, R., Derom, C., Vlietinck, R., & Zeegers, M. P. (2007). Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: Heritabilities. Diabetologia, 50, 2107-2116. (Pubitemid 47373863)
42. Steinberg, D. (2002). Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nature Medicine, 8, 1211-1217. (Pubitemid 35373551)
43. Su, S., Snieder, H., Miller, A. H., Ritchie, J., Bremner, J. D., Goldberg, J., Dai, J., Jones, L., Murrah, N. V., Zhao, J., & Vaccarino, V. (2008). Genetic and environmental influences on systemic markers of inflammation in middle-aged male twins. Atherosclerosis, 200, 213-220.
44. Walldius, G., & Jungner, I. (2004). Apolipoprotein B and apolipoprotein A-I: Risk indicators of coronary heart disease and targets for lipid-modifying therapy. Journal of Internal Medicine, 255, 188-205. (Pubitemid 38241363)
45. Velasquez-Melendez, G., Parra, F. C., Gazzinelli, A., Williams-Blangero, S., & Correa-Oliveira, R. (2007). Genetic determinants of risk factors for cardiovascular disease in a population from rural Brazil. Human Biology, 79, 179-190. (Pubitemid 47623776)
46. Wessel, J., Moratorio, G., Rao, F., Mahata, M., Zhang, L., Greene, W., Rana, B. K., Kennedy, B. P., Khandrika, S., Huang, P., Lillie, E. O., Shih, P. A., Smith, D. W., Wen, G., Hamilton, B. A., Ziegler, M. G., Witztum, J. L., Schork, N. J., Schmid-Schönbein, G. W., & O'Connor, D. T. (2007). C-reactive protein, an 'intermediate phenotype' for inflammation: Human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta- adrenergic pathway loci. Journal of Hypertension, 25, 329-343.
47. Worns, M. A., Victor, A., Galle, P. R., & Hohler, T. (2006). Genetic and environmental contributions to plasma C-reactive protein and interleukin-6 levels: A study in twins. Genes and Immunity, 7, 600-605. (Pubitemid 44614875)